Literature DB >> 20849815

Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.

Steven H Young1, Enrique Rozengurt.   

Abstract

We examined crosstalk between the insulin receptor and G protein-coupled receptor (GPCR) signaling pathways in individual human pancreatic cancer PANC-1 cells. Treatment of cells with insulin (10 ng/ml) for 5 min markedly enhanced the proportion of cells that display an increase in intracellular [Ca²+] induced by picomolar concentrations of the GPCR agonist neurotensin. Interestingly, insulin increased the proportion of a subpopulation of cells that exhibit intracellular [Ca²+] oscillations in response to neurotensin at concentrations as low as 50-200 pM. Insulin enhanced GPCR-induced Ca²+ signaling in a time- and dose-dependent manner; a marked potentiation was obtained after an exposure to a concentration of 10 ng/ml for 5 min. Treatment with the mTORC1 inhibitor rapamycin abrogated the increase in GPCR-induced [Ca²+](i) oscillations produced by insulin. Our results identify a novel aspect in the crosstalk between insulin receptor and GPCR signaling systems in pancreatic cancer cells, namely that insulin increases the number of [Ca²+](i) oscillating cells induced by physiological concentrations of GPCR agonists through an mTORC1-dependent pathway.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849815      PMCID: PMC2952715          DOI: 10.1016/j.bbrc.2010.09.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  Autocrine and paracrine signaling through neuropeptide receptors in human cancer.

Authors:  L E Heasley
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

2.  G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.

Authors:  N M Ryder; S Guha; O J Hines; H A Reber; E Rozengurt
Journal:  J Cell Physiol       Date:  2001-01       Impact factor: 6.384

Review 3.  Gastrin, CCK, signaling, and cancer.

Authors:  E Rozengurt; J H Walsh
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

4.  [D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells.

Authors:  J Sinnett-Smith; C Santiskulvong; J Duque; E Rozengurt
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

5.  Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together?

Authors:  E Bertelli; M Regoli; D Orazioli; M Bendayan
Journal:  Diabetologia       Date:  2001-05       Impact factor: 10.122

6.  Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.

Authors:  L Wang; H Friess; Z Zhu; H Graber; A Zimmermann; M Korc; J C Reubi; M W Büchler
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

7.  Relevant genomics of neurotensin receptor in cancer.

Authors:  J Elek; W Pinzon; K H Park; R Narayanan
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

8.  Diverse somatic mutation patterns and pathway alterations in human cancers.

Authors:  Zhengyan Kan; Bijay S Jaiswal; Jeremy Stinson; Vasantharajan Janakiraman; Deepali Bhatt; Howard M Stern; Peng Yue; Peter M Haverty; Richard Bourgon; Jianbiao Zheng; Martin Moorhead; Subhra Chaudhuri; Lynn P Tomsho; Brock A Peters; Kanan Pujara; Shaun Cordes; David P Davis; Victoria E H Carlton; Wenlin Yuan; Li Li; Weiru Wang; Charles Eigenbrot; Joshua S Kaminker; David A Eberhard; Paul Waring; Stephan C Schuster; Zora Modrusan; Zemin Zhang; David Stokoe; Frederic J de Sauvage; Malek Faham; Somasekar Seshagiri
Journal:  Nature       Date:  2010-07-28       Impact factor: 49.962

9.  Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells.

Authors:  Krisztina Kisfalvi; Cliff Hurd; Sushovan Guha; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

10.  Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.

Authors:  Krisztina Kisfalvi; Guido Eibl; James Sinnett-Smith; Enrique Rozengurt
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

View more
  10 in total

1.  Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.

Authors:  Kristin K Fino; Gail L Matters; Christopher O McGovern; Evan L Gilius; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-22       Impact factor: 4.052

2.  A comprehensive analysis of candidate genes and pathways in pancreatic cancer.

Authors:  Jie Liu; Jun Li; Hali Li; Aidong Li; Biou Liu; Liou Han
Journal:  Tumour Biol       Date:  2014-11-20

3.  Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.

Authors:  Fang Hao; Qinhong Xu; Yinglan Zhao; Jan V Stevens; Steven H Young; James Sinnett-Smith; Enrique Rozengurt
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

Review 4.  Transportome Malfunctions and the Hallmarks of Pancreatic Cancer.

Authors:  Qi Ling; Holger Kalthoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

5.  Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.

Authors:  Heloisa P Soares; Yang Ni; Krisztina Kisfalvi; James Sinnett-Smith; Enrique Rozengurt
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 6.  Endogenous electric fields as guiding cue for cell migration.

Authors:  Richard H W Funk
Journal:  Front Physiol       Date:  2015-05-13       Impact factor: 4.566

Review 7.  The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome.

Authors:  Iryna Liauchonak; Fady Dawoud; Yatin Riat; Bessi Qorri; Manpreet Sambi; Justin Jain; Regina-Veronicka Kalaydina; Nicole Mendonza; Komal Bajwa; Myron R Szewczuk
Journal:  Int J Mol Sci       Date:  2018-02-17       Impact factor: 5.923

8.  Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.

Authors:  Fang Hao; Qinhong Xu; Jing Wang; Shuo Yu; Hui-Hua Chang; James Sinnett-Smith; Guido Eibl; Enrique Rozengurt
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

Review 9.  Obesity and Pancreatic Cancer: Insight into Mechanisms.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Cancers (Basel)       Date:  2021-10-10       Impact factor: 6.639

10.  Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.

Authors:  Ming Ming; James Sinnett-Smith; Jia Wang; Heloisa P Soares; Steven H Young; Guido Eibl; Enrique Rozengurt
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.